Robert McWhirter SQI Diagnostics Inc. SQD-X BUY Sep 30, 2019

They did a recent financing which has a high participation from management. Their system allows you to do a more efficient analysis of blood in a lab. They are approaching the large lab diagnostics companies in the US. They continue to evolve the technology and improve it.

Robert McWhirter

Unknown

Unlock Rating

$0.125

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

COMMENT

Does rapid testing for clinical diagnostics. Has held in quite well. Going through an approval process and it looks like things will be okay. Leveraged earnings are pretty big. Likes the company but is not actively buying it.

BUY

They make life easier for large diagnostic test companies. It automates the testing process. They did a final financing. They've been working on this technology for 5 years.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Robert McWhirter SQI Diagnostics Inc. SQD-X BUY Sep 30, 2019

You might be interested:

SQI Diagnostics Inc.(SQD-X)

SQI Diagnostics Inc.(SQD-X)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights